comparemela.com

Latest Breaking News On - Sour al sain - Page 1 : comparemela.com

People in Kuwait see benefits of TCM in pandemic

China Daily / 2021-03 / 04 / Page018 People in Kuwait see benefits of TCM in pandemic China Daily | Updated: 2021-03-04 00:00 KUWAIT CITY-Witnessing a spike in COVID-19 cases as the pandemic continues to rage globally, Kuwait has enforced several measures to contain the spread of the virus. In this context, Fahd Ghazi al-Mutairi, chairman of Kuwaiti company Sour Al-Sain representing the Chinese drug producer Yiling Pharmaceutical on the Kuwaiti market, reveals that the traditional Chinese medicine Lianhua Qingwen is a good drug to treat coronavirus symptoms. Lianhua Qingwen, a patented traditional Chinese medicine that is widely used in China to treat patients suffering from the coronavirus, has been certified by the Pharmaceutical and Herbal Medicine Registration and Control Administration of Kuwait for the treatment of symptoms caused by COVID-19, Mutairi says.

Kuwaitis praise traditional Chinese medicine for treating COVID-19

news Kuwaitis praise traditional Chinese medicine for treating COVID-19 Nie Yunpeng © Provided by N.C.N. Limited Photo taken on Feb. 28, 2021 shows the traditional Chinese medicine Lianhua Qingwen Capsules at a pharmacy in Kuwait City, Kuwait. (Photo by Asad/Xinhua) Lianhua Qingwen Capsules, a patented traditional Chinese medicine widely used in China to treat COVID-19 patients, has been certified by the Kuwaiti government for use. Many Kuwaitis say the medicine has proven its effectiveness in treating the coronavirus symptoms. KUWAIT CITY, March 3 (Xinhua) Witnessing a spike in COVID-19 cases as the pandemic continues to rage globally, Kuwait has enforced several measures to contain the spread of the virus.

Kuwaitis praise traditional Chinese medicine for treating COVID-19

Kuwaitis praise traditional Chinese medicine for treating COVID-19
globaltimes.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globaltimes.cn Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.